Erganeo
Overview
Erganeo is a French investment fund and technology transfer company specializing in early-stage, deep tech innovations with a strong societal impact, particularly from public research in the Paris region.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| METHYS Dx | May 2023 | Pre Seed | Co-investor |
| ICON Photonics | May 2018 | Accelerator | Co-investor |
| Carboneo | Jan 2022 | Accelerator | Co-investor |
| Lytid | Jun 2017 | Seed | Co-investor |
| Evora Biosciences | - | Angel | Co-investor |
For institutional investors. Book with your work email.
Key People
Boris Goncalves
Portfolio Manager
dai L.
Portfolio Manager
Emmanuel Conseiller
Healthcare Innovation Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Erganeo based?
Erganeo is headquartered in Paris, France.
When was Erganeo founded?
Erganeo was founded in 2012.
How many portfolio companies does Erganeo have?
Erganeo has 6 portfolio companies in Caplight's dataset.
What are some companies in Erganeo's portfolio?
Portfolio companies visible on Caplight include METHYS Dx, ICON Photonics, Carboneo, Lytid, Evora Biosciences.
What was Erganeo's most recent investment shown here?
Erganeo's most recent investment in this portfolio sample was in METHYS Dx in 2023.
What sectors does Erganeo focus on?
Erganeo focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Telecommunications & Networking, Frontier & Industrial Tech, Healthcare & Life Sciences.
What company stages does Erganeo focus on?
Erganeo typically invests at the Early stage.